There were the highest PD‐L1, PD‐L2 genetic alteration frequency in which amplification accounted for the majority in sarcoma tumour samples with the highest genetic amplification frequencies of JAK1 and BTG1 (Figure 4). This evidence concerns the gene CD274 and sarcoma.